Close Menu

layoffs

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Beckman Coulter's president has issued a letter to employees informing them that 8 percent of the company's workforce will be laid off as part of the company's restructuring.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PerkinElmer reduced its number of employees by 72 as part of a restructuring plan during its recently completed second quarter, the company disclosed this week.

The company said in an SEC document it will shrink its workforce by 10 to 15 employees in connection with the integration of its Symyx acquisition.

LabCorp plans to integrate Genzyme Genetics' reimbursement and IT teams at the Westborough, Mass., facility into its own operations.

The firm's Pharmaceutical Divisions will be primarily affected by the job cuts and transfers. The program is expected to result in annual cost savings of CHF2.4 billion ($2.4 billion) for Roche.

The firm also will consolidate its R&D work and leave open job positions unfilled.

The firm's lab services revenues were hurt by lower sample volume, but were partially offset by a higher average price per sample. Celera also announced a restructuring program intended to cut costs by $10 million next year.

The firm, which has been unable to complete a US IPO, has cut staff, consultants, and its board of directors as it seeks funding and potential strategic alternatives.

Pages

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.